Mary Theresa Coelho
Chief Financial Officer, BALCHEM CORP.
Companies
- HOOKIPA Pharma Inc.Chief financial officer Jul 24, 2024 to now1
- Inotiv, Inc.Board member Oct 18, 2023 to now2
- HOOKIPA Pharma Inc.Board member Apr 4, 2023 to now3
- GridAI Technologies Corp.Board member Aug 17, 2021 to Jan 4, 20244
- Gamida Cell Ltd.Chief financial officer May 25, 2023 to Jun 14, 20235
- CinCor Pharma, Inc.Chief financial officer Jan 6, 2022 to Jan 13, 20226
- BIODELIVERY SCIENCES INTERNATIONAL INCOfficer Jan 18, 2019 to Feb 2, 20217
- BALCHEM CORPChief financial officer Oct 25, 2017 to Oct 30, 20188
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- GridAI Technologies Corp. GRDX20,237 shares9$93.1K at $4.60Jan 2, 2024
- Inotiv, Inc.0 shares10Jul 19, 2026
- HOOKIPA Pharma Inc.56,266 shares11Jul 22, 2025
- CinCor Pharma, Inc.100 shares12Jan 11, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 19, 2026Other 74,303 shares of Inotiv, Inc.10
- Jul 22, 2025Sold 13,609 shares at $0.92 of HOOKIPA Pharma Inc.11
- Apr 1, 2025Sold 5,500 shares at $2.35 of Inotiv, Inc.13
- Mar 14, 2025Granted 39,392 shares of Inotiv, Inc.14
- Aug 10, 2024Granted 27,500 shares of Inotiv, Inc.15
- Jul 22, 2024Granted 69,875 shares of HOOKIPA Pharma Inc.16
- Jan 2, 2024Granted 19,633 shares of GridAI Technologies Corp.9
- Oct 17, 2023Granted 12,911 shares of Inotiv, Inc.17
- Jan 3, 2023Granted 84,745 shares of GridAI Technologies Corp.18
- Jan 11, 2022Bought 100 shares at $16.00 of CinCor Pharma, Inc.12
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARInotiv, Inc., Board member
- 3SEC EDGARHOOKIPA Pharma Inc., Board member
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13SEC EDGARForm 4 filed Apr 2, 2025
- 14SEC EDGARForm 4 filed Mar 18, 2025
- 15SEC EDGARForm 4 filed Aug 14, 2024
- 16SEC EDGARForm 4 filed Jul 24, 2024
- 17SEC EDGARForm 4 filed Oct 18, 2023
- 18SEC EDGARForm 4 filed Jan 5, 2023